National brain tumour research funding needs to increase to £35 million a year
Unpublished results of clinical trials pose risk to public health
A new report by the House of Commons Science and Technology Committee says that nearly half of clinical trials' results on new drugs and treatments remain unpublished.
The committee warns that not enough is being done to ensure that the outcomes of all clinical trials are reported and their report indicates that clinicians are therefore making decisions without having all data that could, and should, be available to them.
The report of the Task and Finish Working Group on brain tumour research looked at the current clinical trial network in this country. The report concluded that, 'Only by increasing the number of brain tumour trials on the portfolio can we increase access to research infrastructure at a local level to make these trials available to more patients across more sites in the UK.'
It is also crucial that the data from any brain tumour clinical trial is made available to those who need to make clinical decisions about patient care.
Information about international clinical trials can be found on the EU Clinical Trials Tracker and clinicaltrials.gov.
Please contact us if you'd like more information about our research and how we are looking to feed our findings into clinical trials in the UK. We would love to hear from you.
- Brain Tumour Research welcomes commitment to the funding of clinical trials for cancer treatment
- Results of early-stage clinical trials offer potential therapy options for GBM patients